Related Experiment Video
Updated: Jun 27, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Long-term outcomes of corneal crosslinking
1Thomas Jefferson University.
Corneal crosslinking (CXL) effectively halts progressive keratoconus (KCN) long-term. Newer CXL protocols show similar efficacy and safety to the standard Dresden protocol, though pediatric patients may progress faster.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Vision Science
Background:
- Keratoconus (KCN) is a progressive ectatic disorder affecting corneal shape.
- Standard Dresden Protocol (SDP) has been the gold standard for CXL since the early 2000s.
- Modifications like accelerated and transepithelial CXL aim to improve outcomes and reduce complications.
Purpose of the Study:
- To review contemporary research (2018-2023) on long-term outcomes (≥2 years) of corneal crosslinking (CXL) for progressive keratoconus (KCN).
- To evaluate the efficacy and safety of various CXL protocols in adult and pediatric populations.
Main Methods:
- Systematic review of studies published between 2018 and 2023.
- Analysis of long-term (≥2 years) visual and topographic outcomes.
- Assessment of safety profiles across different CXL protocols.
Main Results:
- The standard Dresden Protocol (SDP) demonstrates long-term disease stabilization and improvement in visual and topographic indices up to 13 years.
- Accelerated and transepithelial CXL protocols are well-tolerated alternatives with comparable efficacy to SDP.
- Pediatric populations showed higher post-CXL progression rates, but all reviewed protocols exhibited excellent safety.
Conclusions:
- SDP remains effective for long-term keratoconus stabilization.
- Newer CXL protocols offer effective alternatives with good safety profiles.
- Pediatric patients may require closer monitoring due to potentially higher progression rates post-CXL.
More Related Videos
12:25Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
Published on: January 6, 2018
05:56Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016